Table 4.
Pre- and post-ablation characteristics in those with primary treatment failure
| Patient | Pre-PGA with IRE | Post-PGA with IRE | |||||
|---|---|---|---|---|---|---|---|
| PSA (ng/dL) | Biopsy grade |
Positive cores* |
Prostate volume† |
PSA (ng/dL) |
Biopsy grade |
Positive cores* |
|
| 1 | 8.8 | 3+3 | 4(14) | 68 | 5.55 | 3+3 | 1(14) |
| 2 | 5.59 | 3+3 | 2(15) | 52 | 4.44 | 3+3 | 1(14) |
| 3 | 3.96 | 3+3 | 3(14) | 54 | 3 | 3+3 | 2(14) |
| 4 | 9.58 | 3+3 | 1(12) | 37 | 14.07 | 3+4 | 4(18) |
*
number of positive cores and (total number of cores obtained)
†
volume (in grams) from pre-operative and 4- to 6-week post-operative MRI